Save time and jump to the most important pieces.
Date | Price Target | Rating | Analyst |
---|---|---|---|
6/6/2025 | $28.00 | Outperform → Neutral | BNP Paribas Exane |
4/9/2025 | $38.00 | Neutral → Buy | ROTH MKM |
4/2/2025 | $37.50 | Hold | Berenberg |
3/6/2025 | $47.00 → $32.00 | Equal-Weight → Underweight | Morgan Stanley |
12/17/2024 | $45.00 → $43.00 | Neutral → Underweight | Analyst |
12/16/2024 | $50.00 → $45.00 | Buy → Hold | Truist |
12/6/2024 | Hold | Needham | |
11/25/2024 | $48.00 | Outperform | Exane BNP Paribas |
4 - BROWN FORMAN CORP (0000014693) (Issuer)
4 - BROWN FORMAN CORP (0000014693) (Issuer)
4 - BROWN FORMAN CORP (0000014693) (Issuer)
8-K - BROWN FORMAN CORP (0000014693) (Filer)
8-K - BROWN FORMAN CORP (0000014693) (Filer)
8-K - BROWN FORMAN CORP (0000014693) (Filer)
BNP Paribas Exane downgraded Brown-Forman from Outperform to Neutral and set a new price target of $28.00
ROTH MKM upgraded Brown-Forman from Neutral to Buy and set a new price target of $38.00
Berenberg initiated coverage of Brown-Forman with a rating of Hold and set a new price target of $37.50
SC 13G/A - BROWN FORMAN CORP (0000014693) (Subject)
SC 13G/A - BROWN FORMAN CORP (0000014693) (Subject)
SC 13G/A - BROWN FORMAN CORP (0000014693) (Subject)